
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC300cc-11]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
  SUBCHAPTER XXI--RESEARCH WITH RESPECT TO ACQUIRED IMMUNE DEFICIENCY 
                                SYNDROME
 
                       Part B--Research Authority
 
Sec. 300cc-11. Clinical evaluation units at National Institutes 
        of Health
        

(a) In general

    The Secretary, acting through the Director of the National Cancer 
Institute and the Director of the National Institute of Allergy and 
Infectious Diseases, shall for each such Institute establish a clinical 
evaluation unit at the Clinical Center at the National Institutes of 
Health. Each of the clinical evaluation units--
        (1) shall conduct clinical evaluations of experimental 
    treatments for acquired immune deficiency syndrome developed within 
    the preclinical drug development program, including evaluations of 
    methods of diagnosing immune deficiency and evaluations of methods 
    of predicting, diagnosing, preventing, and treating opportunistic 
    cancers and infectious diseases; and
        (2) may conduct clinical evaluations of experimental treatments 
    for such syndrome that are developed by any other national research 
    institute of the National Institutes of Health or by any other 
    entity.

(b) Personnel and administrative support

    (1) For the purposes described in subsection (a) of this section, 
the Secretary, acting through the Director of the National Institutes of 
Health, shall provide each of the clinical evaluation units required in 
such subsection--
        (A)(i) with not less than 50 beds; or
        (ii) with an outpatient clinical capacity equal to not less than 
    twice the outpatient clinical capacity, with respect to acquired 
    immune deficiency syndrome, possessed by the Clinical Center of the 
    National Institutes of Health on June 1, 1988; and
        (B) with such personnel, such administrative support, and such 
    other support services as may be necessary.

    (2) Facilities, personnel, administrative support, and other support 
services provided pursuant to paragraph (1) shall be in addition to the 
number or level of facilities, personnel, administrative support, and 
other support services that otherwise would be available at the Clinical 
Center at the National Institutes of Health for the provision of 
clinical care for individuals with diseases or disorders.

(c) Authorization of appropriations

    For the purpose of carrying out this section, there are authorized 
to be appropriated such sums as may be necessary.

(July 1, 1944, ch. 373, title XXIII, Sec. 2311, as added Pub. L. 100-
607, title II, Sec. 201(4), Nov. 4, 1988, 102 Stat. 3066; amended Pub. 
L. 103-43, title XVIII, Sec. 1811(2), June 10, 1993,107 Stat. 199.)


                            Prior Provisions

    A prior section 300cc-11, act July 1, 1944, Sec. 2312, was 
successively renumbered by subsequent acts and transferred, see section 
238i of this title.


                               Amendments

    1993--Subsec. (a)(1). Pub. L. 103-43 inserted before semicolon at 
end ``, including evaluations of methods of diagnosing immune deficiency 
and evaluations of methods of predicting, diagnosing, preventing, and 
treating opportunistic cancers and infectious diseases''.
